Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD

Summary

Recruitment of patients with COPD. Assessment of clinical status, determination of vitamin D and cathelicidin levels. In the group with vitamin D deficiency, patients receive cholecalciferol (vitamin D) daily for 3 months. After 3 months, the clinical status was assessed again, the level of vitamin D and cathelicidin was determined. When vitamin D levels normalize, cholecalciferol replacement therapy is discontinued for 3 months. After that, a control inspection and laboratory tests are performed.

Timeline

Start

2020-02-18

Primary completion

2021-12-30

Completion

2021-12-31

Drugs

Indications